Changes in Antimicrobial Resistance in Pediatric Urinary Pathogens Before, During, and After the COVID-19 Pandemic

Seon Hee Lim1, Kyo Jin Jo1, Shin Yun Byun1

  • 1Department of Pediatrics, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea.

PubMed

Insights

Pediatric urinary tract infections (UTIs) saw increased ciprofloxacin resistance during the COVID-19 pandemic, particularly in infants. This trend persisted post-pandemic, underscoring the need for better antibiotic stewardship.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Resistance (AMR)
  • Epidemiology

Background:

  • Pediatric urinary tract infections (UTIs) pose treatment challenges due to rising antimicrobial resistance (AMR).
  • The COVID-19 pandemic influenced antibiotic prescribing patterns in children, but its effect on AMR trends was unclear.
  • Investigating AMR trends in young children hospitalized with febrile UTI during different pandemic phases is crucial.

Purpose of the Study:

  • To analyze antimicrobial resistance (AMR) trends in urinary pathogens from children under 24 months hospitalized with febrile UTI.
  • To compare AMR patterns during the pre-, during-, and post-COVID-19 pandemic periods.
  • To identify predictors of ciprofloxacin nonsusceptibility in pediatric febrile UTI.

Main Methods:

  • Retrospective study of children aged <24 months hospitalized for first febrile UTI (2008-2023).
  • Stratification by age (<100 days vs. 100 days-24 months) and pandemic period (pre-, during-, post-COVID-19).
  • Interrupted time-series (ITS) analysis and logistic regression to assess trends and predictors of ciprofloxacin nonsusceptibility.

Main Results:

  • Ciprofloxacin susceptibility significantly decreased during the COVID-19 pandemic, especially in infants <100 days.
  • ITS analysis revealed an immediate 12.1% increase in ciprofloxacin nonsusceptibility at pandemic onset, which continued.
  • Extended-spectrum β-lactamase (ESBL) production was the strongest predictor of ciprofloxacin resistance.

Conclusions:

  • The study indicates a significant rise in ciprofloxacin nonsusceptibility in pediatric febrile UTI during the COVID-19 pandemic.
  • Adult antibiotic use and clonal spread may drive AMR persistence and dissemination.
  • Integrated antibiotic stewardship and genomic surveillance are essential for combating pediatric AMR.
Abstract

Related Concept Videos

Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
736
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
191
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
228
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
524
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.1K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
876